Photodynamic therapy in the canine prostate using motexafin lutetium.
暂无分享,去创建一个
M Saunders | A. Kapatkin | M. Solonenko | T. Vulcan | R A Hsi | A Kapatkin | J Strandberg | T Zhu | T Vulcan | M Solonenko | C Rodriguez | J Chang | N Mason | S Hahn | C. Rodriguez | R. Hsi | John D. Strandberg | T. C. Zhu | John Chang | Mark P Saunders | Nicole Mason | Stephen M. Hahn
[1] D. Ornstein,et al. Evaluation and management of the man who has failed primary curative therapy for prostate cancer. , 1998, The Urologic clinics of North America.
[2] B. Overholt,et al. Photodynamic therapy for Barrett's esophagus. , 1997, Gastrointestinal endoscopy clinics of North America.
[3] A. D'Amico,et al. Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Shi-Chung Chang,et al. Interstitial and transurethral photodynamic therapy of the canine prostate using meso‐tetra‐(m‐hydroxyphenyl) chlorin , 1996, International journal of cancer.
[5] F. Hetzel,et al. Interstitial photodynamic therapy in the canine prostate. , 1997, British journal of urology.
[6] M. A. Samphilipo,et al. Multimodality Correlative Study of Canine Brain Tumors: Proton Magnetic Resonance Spectroscopy, Positron Emission Tomography, and Histology , 1994, Investigative radiology.
[7] R. Keck,et al. Transperineal photodynamic ablation of the canine prostate. , 1996, The Journal of urology.
[8] C. Whitehurst,et al. In vivo laser light distribution in human prostatic carcinoma. , 1994, The Journal of urology.
[9] Shi-Chung Chang,et al. Interstitial photodynamic therapy in the canine prostate with disulfonated aluminum phthalocyanine and 5‐aminolevulinic acid‐induced protoporphyrin IX , 1997, The Prostate.
[10] Darren L. Johnson. Photodynamic Therapy for Barrett's Esophagus , 2000 .
[11] R. Stock,et al. Prostate brachytherapy: Improvements in prostate volume measurements and dose distribution using interactive ultrasound guided implantation and three-dimensional dosimetry , 1995 .
[12] M. Marberger,et al. Predictability and significance of multifocal prostate cancer in the radical prostatectomy specimen. , 1999, Techniques in urology.
[13] J. Sessler,et al. Lutetium Texaphyrin (PCI‐0123): A Near‐Infrared, Water‐Soluble Photosensitizer , 1996, Photochemistry and photobiology.
[14] M. Biel. Photodynamic therapy and the treatment of head and neck neoplasia , 1998, The Laryngoscope.
[15] D. V. Ash,et al. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. , 1994, British Journal of Cancer.
[16] B. Wilson,et al. Changes in in vivo optical properties and light distributions in normal canine prostate during photodynamic therapy. , 1997, Radiation research.
[17] D. Kessel,et al. Localization and Efficacy Analysis of the Phototherapeutic Lutetium Texaphyrin (PCI‐0123) in the Murine EMT6 Sarcoma Model , 1997, Photochemistry and photobiology.
[18] Q. Peng,et al. Photodynamic Therapy , 1988, Methods in Molecular Biology.
[19] J. H. Kinsey,et al. Photodynamic therapy for early stage squamous cell carcinoma of the lung. , 1997, Mayo Clinic proceedings.